Home NDC 71336-1003 AMVUTTRA
Product NDC 71336-1003
11-digit product format 713361003
Labeler code 71336
Product ID 71336-1003_1791a81a-d261-4b66-b699-273afe02c380
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name VUTRISIRAN
Dosage form INJECTION
Route SUBCUTANEOUS
Labeler Alnylam Pharmaceuticals, Inc.
Application NDA215515
Marketing category NDA
Marketing start 2022-06-13
Substance VUTRISIRAN SODIUM
Active strength 25 mg/.5mL
Pharmacologic classes Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215515-001 AMVUTTRA VUTRISIRAN SODIUM EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13
Orange Book patents# Current patent rows page 1 of 1 · 13 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215515-001 10131907 2028-08-24 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 10806791 2028-12-04 Drug substance 2022-07-13 N215515-001 8828956 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 9370581 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 8106022 2029-12-12 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 10570391 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 9399775 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 10612024 2035-08-14 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 11401517 2035-08-14 U-3396 Drug substance, Drug product 2022-08-31 N215515-001 10208307 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 10683501 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 11286486 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 N215515-001 12049628 2036-07-28 U-3396 Drug substance, Drug product 2024-08-28
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N215515-001 AMVUTTRA 25MG/0.5ML (25MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N215515-001 AMVUTTRA 25MG/0.5ML (25MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N215515-001 AMVUTTRA 25MG/0.5ML (25MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N215515-001 AMVUTTRA 25MG/0.5ML (25MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N215515-001 AMVUTTRA 25MG/0.5ML (25MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215515-001 AMVUTTRA EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-06-13 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 9 · 335 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215515-001 10131907 2028-08-24 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 10806791 2028-12-04 Drug substance 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 8828956 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 9370581 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 8106022 2029-12-12 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 10570391 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 9399775 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 10612024 2035-08-14 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 11401517 2035-08-14 U-3396 Drug substance, Drug product 2022-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 10208307 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 10683501 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 11286486 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215515-001 12049628 2036-07-28 U-3396 Drug substance, Drug product 2024-08-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10131907 2028-08-24 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10806791 2028-12-04 Drug substance 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 8828956 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 9370581 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 8106022 2029-12-12 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10570391 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 9399775 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10612024 2035-08-14 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 11401517 2035-08-14 U-3396 Drug substance, Drug product 2022-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10208307 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 10683501 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 11286486 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215515-001 12049628 2036-07-28 U-3396 Drug substance, Drug product 2024-08-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215515-001 10131907 2028-08-24 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 10806791 2028-12-04 Drug substance 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 8828956 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 9370581 2028-12-04 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 8106022 2029-12-12 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 10570391 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 9399775 2032-11-16 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 10612024 2035-08-14 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 11401517 2035-08-14 U-3396 Drug substance, Drug product 2022-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 10208307 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 10683501 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 11286486 2036-07-28 U-3396 Drug substance, Drug product 2022-07-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215515-001 12049628 2036-07-28 U-3396 Drug substance, Drug product 2024-08-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215515-001 10131907 2028-08-24 U-3396 Drug substance, Drug product 2022-07-13 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 56 observed states.
Additional Listing Data#
Finished product Yes
Brand name base AMVUTTRA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VUTRISIRAN SODIUM 25 mg/.5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 28O0WP6Z1P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2604788 Internal RxNorm lookup 2604794 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71336-1003-1 AMVUTTRA 1 in 1 CARTON INJECTION 1 8 71336-1003-1 AMVUTTRA 0.5 mL in 1 SYRINGE, GLASS INJECTION 0.5 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71336-1003 AMVUTTRA (VUTRISIRAN) INJECTION [ALNYLAM PHARMACEUTICALS, INC.] 7 Current NDC, Legacy NDC, 2 package rows 20250331_8db0facb-81b6-4006-9239-27dc6409c5d3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71336-1003-1 71336100301 1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS 2022-06-13 0000-00-00 No No Current